Eric SmithDirector, Bispecifics at Regeneron PharmaceuticalsSpeaker
Profile
Dr. Eric Smith received his Ph.D. in Microbiology and Immunology from Duke University in 1997. Following a postdoctoral fellowship at NYU he joined Regeneron in 2002 as a member of the Antibody and Trap Technologies group, where he worked on cytokine traps and related molecules. In 2008 he was a founding member of the Bispecific Antibodies team and is currently the Sr. Director of Bispecifics at Regeneron.
Agenda Sessions
Combination Strategies to Enhance Anti-tumor T Cell Responses
, 14:25View Session